H
HETERO FZCO
Founded in 1993 and headquartered in Hyderabad, India, Hetero is a global vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.
Country/Area ：United Arab Emirates
Company Email ：info@heteroeurope.com
Industry ：Health Care Providers and ServicesHealthcarePharmaceuticals
Company address ：7-2-a2 Hetero Corporate Industrial Estates Sanath Nagar, Hyderabad, Telangana, India
Company website ：*****
Company phone ：(732) 529-0422
Established ：1993
Company Revenue ：$7,088,920,000
Number of employees ：21000
SIC Code ：28283
NAICS Code ：32325
Main Products ：nirmatrelvirMolnupiravirritonavir
Company News
Hetero unveils new logo, corporate brand identity - Medical Dialogues
May 12, 2022
The new logo is effective immediately and will be implemented across the Group's companies, solutions, assets, services, and products in due course, the release added.
May 12, 2022
India's Hetero gets emergency use nod to make Roche's COVID-19 drugSep 6, 2021
Indian drug developer Hetero said on Monday it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug. Hetero expects to make the treatment, tocilizumab, available in India by the end of the month under the brand name Tocira. Tocilizumab has been facing a global shortage as the highly contagious COVID-19 Delta variant drives up cases in several countries.
Sep 6, 2021Bristol-Myers Unit Settles Over Generic Cancer Drug - Law360Aug 20, 2021
Bristol-Myers unit Celgene has reached a settlement with India-based Hetero Labs, marking the final settlement to come out of Celgene's 2017 lawsuit against a raft of generic-drug makers over patents for its blockbuster cancer medication Pomalyst, according to a consent judgement approved Thursday in New Jersey federal court.
Aug 20, 2021Hetero recalls a batch of its remdesivir brand Covifor after side effectsMay 4, 2021
Some patients in Raigad district of Maharashtra developed side effects like fever and chills
May 4, 2021Hetero Labs to manufacture 100 mn doses of Sputnik V vaccine for IndiaNov 27, 2020
Requests for more than 1.2 billion doses of Sputnik V vaccine came from more than 50 countries, RDIF claimed
Nov 27, 2020Web Summary
Q1: What is the address of Hetero FZCO's headquarters?
A1: The address of Hetero Labs Limited, the company's headquarters, is located in Raidurg, Hyderabad - 500081, Telangana, India.
Q2: Where are Hetero Labs Limited's other offices located?
A2: Apart from its headquarters in Hyderabad, Hetero Labs Limited also has offices in Mumbai (International Marketing – Global Access & Africa Region) and Nanjing (Hetero Labs Limited, Nanjing Rep. Office).
Q3: What is the company's industry?
A3: Hetero FZCO operates in the pharmaceutical industry, specifically in the production of APIs, global generics, biosimilars, and custom pharmaceutical services.
Q4: What are some of the company's key products?
A4: Some of the company's key products include anti-retroviral drugs for the treatment of HIV/AIDS, as well as other medications such as Movfor (Molnupiravir), which is a generic version of COVID-19.
Q5: How does Hetero FZCO approach its global presence?
A5: The company has expanded its presence to serve more people and create meaningful impact through its global access strategy, which aims to transform standards of care and make high-quality medicines accessible to the world's poorest parts.
Q6: What is Hetero FZCO's focus on sustainability?
A6: The company has a strong focus on sustainability, with a constant emphasis on sustainable environment, health and safety, community, and responsible business practices. It aims to report comprehensively and transparently for all stakeholders.
Q7: How does Hetero FZCO approach its research and development efforts?
A7: The company invests in cutting-edge research to develop new cures for challenging diseases, with a focus on researching areas of unmet medical need and leveraging advanced R&D capabilities.
Q8: What is the company's commitment to social responsibility?
A8: Hetero FZCO is committed to making a positive impact by contributing to healthy communities and leading a responsible business. It has received several awards for its efforts, including being acknowledged for its contributions to the global HIV response.
A1: The address of Hetero Labs Limited, the company's headquarters, is located in Raidurg, Hyderabad - 500081, Telangana, India.
Q2: Where are Hetero Labs Limited's other offices located?
A2: Apart from its headquarters in Hyderabad, Hetero Labs Limited also has offices in Mumbai (International Marketing – Global Access & Africa Region) and Nanjing (Hetero Labs Limited, Nanjing Rep. Office).
Q3: What is the company's industry?
A3: Hetero FZCO operates in the pharmaceutical industry, specifically in the production of APIs, global generics, biosimilars, and custom pharmaceutical services.
Q4: What are some of the company's key products?
A4: Some of the company's key products include anti-retroviral drugs for the treatment of HIV/AIDS, as well as other medications such as Movfor (Molnupiravir), which is a generic version of COVID-19.
Q5: How does Hetero FZCO approach its global presence?
A5: The company has expanded its presence to serve more people and create meaningful impact through its global access strategy, which aims to transform standards of care and make high-quality medicines accessible to the world's poorest parts.
Q6: What is Hetero FZCO's focus on sustainability?
A6: The company has a strong focus on sustainability, with a constant emphasis on sustainable environment, health and safety, community, and responsible business practices. It aims to report comprehensively and transparently for all stakeholders.
Q7: How does Hetero FZCO approach its research and development efforts?
A7: The company invests in cutting-edge research to develop new cures for challenging diseases, with a focus on researching areas of unmet medical need and leveraging advanced R&D capabilities.
Q8: What is the company's commitment to social responsibility?
A8: Hetero FZCO is committed to making a positive impact by contributing to healthy communities and leading a responsible business. It has received several awards for its efforts, including being acknowledged for its contributions to the global HIV response.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
